Carlsmed, Inc. GAAP EPS of -$0.40 beats by $0.02, revenue of $13.1M beats by $1.72M [Seeking Alpha]
Carlsmed, Inc. (CARL)
Company Research
Source: Seeking Alpha
Carlsmed, Inc. reports Q2 results Carlsmed initiated with Buy at Truist on business potential Seeking Alpha's Quant Rating on Carlsmed, Inc. Historical earnings data for Carlsmed, Inc. Financial information for Carlsmed, Inc.
Show less
Read more
Impact Snapshot
Event Time:
CARL
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CARL alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CARL alerts
High impacting Carlsmed, Inc. news events
Weekly update
A roundup of the hottest topics
CARL
News
- Carlsmed Announces U.S. Launch of its aprevo® Technology Platform for Cervical Fusion Surgeries at the Cervical Spine Research Society (CSRS) 53rd Annual MeetingGlobeNewswire
- Carlsmed (NASDAQ:CARL) had its "sell (e)" rating reaffirmed by analysts at <a style="font-weight:bold" href="https://weissratings.com/">Weiss Ratings</a>.MarketBeat
- Carlsmed, Inc. To Participate in the Piper Sandler 37th Annual Healthcare Conference [Yahoo! Finance]Yahoo! Finance
- Carlsmed, Inc. To Participate in the Piper Sandler 37th Annual Healthcare ConferenceGlobeNewswire
- Carlsmed (NASDAQ:CARL) was upgraded by analysts at <a style="font-weight:bold" href="https://www.wallstreetzen.com/newsletters/zen-ratings?ticker=CARL&utm_campaign=getratings&utm_medium=online&utm_source=MarketBeat">Wall Street Zen</a> fMarketBeat
CARL
Earnings
- 11/6/25 - Beat
CARL
Analyst Actions
- 11/7/25 - BTIG
CARL
Sec Filings
- 11/14/25 - Form SCHEDULE
- 11/6/25 - Form 10-Q
- 11/6/25 - Form 8-K
- CARL's page on the SEC website